The US Food and Drug Administration (FDA) on Wednesday launched a new website aimed at improving access to information that can help healthcare professionals determine which drugs are most likely to ...

A randomized trial involving gram-negative bacterial bloodstream infections found that rapid antibiotic susceptibility testing (AST) was not superior to usual testing in terms of clinical outcomes.

Sepsis remains a substantial disease burden worldwide, and patients can deteriorate rapidly, but the current diagnostics take ...

The field of antimicrobial susceptibility testing (AST) and resistance detection is rapidly evolving to address the global threat posed by antimicrobial resistance. In recent years, a ...

McGill researchers have developed a diagnostic system capable of identifying bacteria—and determining which antibiotics can stop them—in just 36 minutes, a major advance in the global effort to curb ...

Investigators at the Israel Institute for Biological Research have developed a rapid AST that can be performed directly on blood and environmental soil samples. 2,3 In a recent study, the ...

In what represents the first patenting from Glasgow-based Microplate Dx Ltd., three of its co-founders describe a system for diagnosing microbial infections and performing rapid antimicrobial ...

An international trial found that rapid antimicrobial susceptibility testing (AST) for gram-negative bloodstream infections did not significantly improve 30-day survival or other major clinical ...

April 27 (Reuters) - Medical equipment maker Thermo Fisher Scientific said on Monday it would sell its microbiology business to private equity firm Astorg for about $1.08 billion. • Deal consists of ...

New innovations improve microbial identification, outbreak tracking, and NGS workflows, enhancing diagnostic speed, accuracy, ...